MyMD Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
MyMD Pharmaceuticals, Inc.‘s stocks are currently a part of 30 hedge funds’ portfolios, which represents 42.04% of the total amount of its stocks outstanding. This makes up a total of 1.86M shares of MyMD Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -52.07% or -2.03M shares fewer. As for the holding position changes, 23.33% (7) of current hedge fund investors increased the number of shares held, 13.33% (4) of current holders sold a part of the shares held, and 10% (3) closed the holdings completely. 10 hedge funds are new holders of MyMD Pharmaceuticals, Inc. stock in Q1 2023, it is 33.33% of total holders.
Hedge funds holding MyMD Pharmaceuticals (Q3 2017 – Q1 2023)
| Q3 2017 | 1 |
|---|---|
| Q4 2017 | 0 |
| Q2 2018 | 1 |
| Q3 2018 | 0 |
| Q3 2019 | 2 |
| Q4 2019 | 7 |
| Q1 2020 | 10 |
| Q2 2020 | 8 |
| Q3 2020 | 14 |
| Q4 2020 | 15 |
| Q1 2021 | 17 |
| Q2 2021 | 21 |
| Q3 2021 | 27 |
| Q4 2021 | 39 |
| Q1 2022 | 33 |
| Q2 2022 | 34 |
| Q3 2022 | 41 |
| Q4 2022 | 38 |
| Q1 2023 | 30 |
Hedge funds changes in MyMD Pharmaceuticals positions (Q3 2017 – Q1 2023)
| Q3 2017 | 1 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q4 2017 | 0 | 0 | 0 | 1 | -1 |
| Q2 2018 | 1 | 0 | 0 | 0 | 0 |
| Q3 2018 | 0 | 0 | 0 | 1 | -1 |
| Q3 2019 | 2 | 0 | 0 | 0 | 0 |
| Q4 2019 | 5 | 0 | 1 | 0 | 1 |
| Q1 2020 | 5 | 1 | 2 | 2 | 0 |
| Q2 2020 | 2 | 2 | 0 | 4 | 0 |
| Q3 2020 | 9 | 1 | 1 | 3 | 0 |
| Q4 2020 | 6 | 2 | 3 | 4 | 0 |
| Q1 2021 | 6 | 3 | 2 | 4 | 2 |
| Q2 2021 | 21 | 0 | 0 | 17 | -17 |
| Q3 2021 | 9 | 7 | 6 | 2 | 3 |
| Q4 2021 | 14 | 12 | 6 | 2 | 5 |
| Q1 2022 | 5 | 6 | 13 | 11 | -2 |
| Q2 2022 | 8 | 4 | 13 | 8 | 1 |
| Q3 2022 | 15 | 7 | 8 | 8 | 3 |
| Q4 2022 | 6 | 13 | 8 | 9 | 2 |
| Q1 2023 | 10 | 7 | 4 | 3 | 6 |
Hedge funds changes in MyMD Pharmaceuticals stock options (Q3 2017 – Q1 2023)
| Q3 2017 | 0 | 0 |
|---|---|---|
| Q4 2017 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 0 | 0 |
| Q2 2021 | 88,000 | 0 |
| Q3 2021 | 262,000 | 112,000 |
| Q4 2021 | 750,000 | 440,000 |
| Q1 2022 | 228,000 | 196,000 |
| Q2 2022 | 8,000 | 0 |
| Q3 2022 | 383,000 | 231,000 |
| Q4 2022 | 123,900 | 68,445 |
| Q1 2023 | 56,942,000 | 21,512,000 |